| Product Name | NebuSelect™ Recombinant Human IL-7R alpha/CD127, hFc-tag |
|---|---|
| Catalog Number | NBL-242467 |
| Alias/Synonyms | IL-7R alpha/CD127; IL-17R alpha; IL7Ra; CD127; CDW127; ILRA |
| Appearance | see COA |
| Molecule Weight | |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | P16871-1 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-242467-100ug | 100ug | Inquire | Inquire | |
| NBL-242467-1mg | 1mg | Inquire | Inquire | |
| NBL-242467-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human IL-7R alpha/CD127, hFc-tag
Catalog#:
NBL-242467
Description:
NebuSelect™ Recombinant Human IL-7R alpha/CD127, hFc-tag(Cat#NBL-242467) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Glu21-Gly236.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 51.6 kDa. Due to glycosylation, the protein migrates to 65-75 kDa based on Bis-Tris PAGE result.
Target Name:
IL-7R alpha/CD127; IL-17R alpha; IL7Ra; CD127; CDW127; ILRA
Target Information:
Interleukin 7 (IL-7) and its receptor (IL-7R, a heterodimer of IL-7Rα and γc) are essential for normal lymphoid development. IL-7 and IL-7R activate three main pathways: STAT5, PI3K/Akt/mTOR and MEK/Erk, ultimately leading to the promotion of leukemia cell viability, cell cycle progression and growth.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.